| Walmart Pharmacy 10-3275 | |
| 1101 Nw 164th St, Edmond, Oklahoma 73013 | |
| (405) 216-8375 |
| Name | Walmart Pharmacy 10-3275 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 1101 Nw 164th St, Edmond, Oklahoma 73013 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (405) 216-8375 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The European Union's Research Executive Agency has given the Technische Universitaet Muenchen (TUM) a green light to begin negotiations on a five-year co-funding grant. In a ranking of 70 proposals for COFUND support through the Marie Curie Program, a TUM proposal requesting 6.2 million euros to expand selected programs of the TUM Institute for Advanced Study was one of just 18 to win the top "A" rating.
Study results published today in the National Kidney Foundation's American Journal of Kidney Diseases provide new insights into why a child's chronic kidney disease (CKD) may worsen to kidney failure.
New research from the Netherlands shows that the switch from screen film mammography (SFM) to digital mammography (DM) in large, population-based breast cancer screening programs improves the detection of life-threatening cancer without significantly increasing detection of clinically insignificant disease. Results of the study are published online in the journal Radiology.
The Institute of Materia Medica (IMM), a member of the Chinese Academy of Medical Sciences, and the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of new TB drugs, today announced plans to pursue a joint research partnership to develop promising, novel anti-tuberculosis agents.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.
› Verified 3 days ago
| NPI Number | 1568481570 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WAL-MART PHARMACY 10-3275 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1101 Nw 164th St, Edmond, OK 73013 |
| Phone Number | 405-216-8375 |
News Archive
The European Union's Research Executive Agency has given the Technische Universitaet Muenchen (TUM) a green light to begin negotiations on a five-year co-funding grant. In a ranking of 70 proposals for COFUND support through the Marie Curie Program, a TUM proposal requesting 6.2 million euros to expand selected programs of the TUM Institute for Advanced Study was one of just 18 to win the top "A" rating.
Study results published today in the National Kidney Foundation's American Journal of Kidney Diseases provide new insights into why a child's chronic kidney disease (CKD) may worsen to kidney failure.
New research from the Netherlands shows that the switch from screen film mammography (SFM) to digital mammography (DM) in large, population-based breast cancer screening programs improves the detection of life-threatening cancer without significantly increasing detection of clinically insignificant disease. Results of the study are published online in the journal Radiology.
The Institute of Materia Medica (IMM), a member of the Chinese Academy of Medical Sciences, and the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of new TB drugs, today announced plans to pursue a joint research partnership to develop promising, novel anti-tuberculosis agents.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.
› Verified 3 days ago
News Archive
The European Union's Research Executive Agency has given the Technische Universitaet Muenchen (TUM) a green light to begin negotiations on a five-year co-funding grant. In a ranking of 70 proposals for COFUND support through the Marie Curie Program, a TUM proposal requesting 6.2 million euros to expand selected programs of the TUM Institute for Advanced Study was one of just 18 to win the top "A" rating.
Study results published today in the National Kidney Foundation's American Journal of Kidney Diseases provide new insights into why a child's chronic kidney disease (CKD) may worsen to kidney failure.
New research from the Netherlands shows that the switch from screen film mammography (SFM) to digital mammography (DM) in large, population-based breast cancer screening programs improves the detection of life-threatening cancer without significantly increasing detection of clinically insignificant disease. Results of the study are published online in the journal Radiology.
The Institute of Materia Medica (IMM), a member of the Chinese Academy of Medical Sciences, and the Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of new TB drugs, today announced plans to pursue a joint research partnership to develop promising, novel anti-tuberculosis agents.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS(R) Liberté(R) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberté Stent when compared to the first-generation TAXUS(R) Express(R) Stent.
› Verified 3 days ago
Cvs Pharmacy #06096 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1301 N Santa Fe Ave, Edmond, Oklahoma 73003 Phone: (405) 340-0522 | |
Cvs Pharmacy #06225 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1520 S Bryant Ave, Edmond, Oklahoma 73013 Phone: (405) 348-7982 | |
Cvs Pharmacy #06233 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1308 N Bryant Ave, Edmond, Oklahoma 73034 Phone: (405) 359-1025 | |
Cvs Pharmacy #06234 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3200 S Santa Fe Ave, Edmond, Oklahoma 73013 Phone: (405) 330-8107 | |
Cvs Pharmacy #02512 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 17850 N Pennsylvania Ave, Edmond, Oklahoma 73012 Phone: (405) 341-1142 |